Pharma Archives - Page 46 of 48 - Life Sciences Times

Casma Therapeutics Announces CEO Transition

January 31, 2023

Miach Orthopaedics Secures $40 Million Financing

January 25, 2023

Maugel DeStefano Architects and The Richmond Group Complete KSQ Therapeutics R&D Facility

January 10, 2023

Colliers Advises Vibalogics in 118,000-SF Life Science Deal in Boxborough

November 13, 2020

New England Biolabs Leases 28,000 SF

December 7, 2020

Boston Properties Announces 138,000 Square Foot, 10-Year Lease With Translate Bio in Waltham, Massachusetts

November 10, 2020

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Pharma

Virpax Pharmaceuticals Engages New England Investors to Direct Licensing Strategy for Envelta™ in China

Stemline Therapeutics, a Subsidiary of Menarini Group, Receives U.S. FDA Approval for ORSERDU™ (elacestrant) as the First and Only Treatment Specifically Indicated for Patients...

Spesolimab meets primary and key secondary endpoint for prevention of generalized pustular psoriasis flares

Aptar Pharma Launches First Metal-Free Nasal Spray Pump, Meeting Growing Need for Highly Recyclable Packaging

Legend Biotech Announces Phase 3 CARTITUDE-4 Study of CARVYKTI® (ciltacabtagene autoleucel) Has Met Its Primary Endpoint in the Treatment of Patients with Relapsed and...

Most Read

Largest OB/GYN in the Southeast with 200+ Providers Selects eClinicalWorks Cloud EHR and healow solutions

Vision Research Supplies Embedded Phantom High-Speed Camera for Use With FDA-Cleared Sepsis Test

Charles River Associates (CRA) Expands Its Forensic Services Practice

Cagent Vascular announces superior lumen gain, greater volumetric blood flow using Serration Angioplasty: A sub-analysis of the PRELUDE BTK study

EDITOR PICKS